logo

For the Inventor, By the Inventor

Urayasu, Japan

Kazuteru Yokose

This inventor holds 6 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1980-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuteru Yokose. Retrieved from https://idiyas.com/inventor/kazuteru-yokose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 110(Granted Patents)


Company Filing History:

goldMedal6 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 1980-1990

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4966891 - Fluorocytidine derivatives (1990-10-30),
2. 4864023 - Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives (1989-09-05),
3. 4801584 - Pyrido(3,2,1-IJ)-1,3,4 benzoxadiazine derivatives (1989-01-31),
4. 4273765 - Amino sugar derivatives containing trehalose (1981-06-16),
5. 4204044 - Process for the manufacture of optically active (1980-05-20),
6. 4202943 - Resolution of a racemate (1980-05-13),

Title: Innovations of Kazuteru Yokose: A Pioneer in Pharmaceutical Patents

Introduction

Kazuteru Yokose, an esteemed inventor based in Urayasu, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio comprising six patents, his work primarily focuses on compounds with potential antitumor properties, reflecting his commitment to advancing medical science.

Latest Patents

Among Kazuteru Yokose's latest innovations are two notable patents. The first is centered around fluorocytidine derivatives, which are novel 5'-deoxy-5-fluorocytidine derivatives designed to possess antitumor activity. These compounds can be synthesized from specific precursors where at least one of R¹, R², and R³ is an easily hydrolyzable radical under physiological conditions. The second patent involves pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives. This invention addresses tricyclic compounds that may include substituents like halogens and radicals from lower aliphatic compounds. Both patents showcase Kazuteru's innovative approach to creating effective therapeutic agents.

Career Highlights

Kazuteru Yokose's career, marked by his position at Hoffmann-La Roche Inc., highlights his impact on pharmaceutical research and development. His expertise and dedication have been instrumental in advancing novel compounds that may one day provide new treatment options for serious health conditions.

Collaborations

Throughout his career, Kazuteru has collaborated with esteemed colleagues, including Yasuji Suhara and Morio Fujiu. These collaborations have fostered a creative environment that has spurred innovative ideas and led to groundbreaking advancements in drug development.

Conclusion

Kazuteru Yokose stands as a prominent figure in the realm of pharmaceutical innovations. His cutting-edge patents and collaborations with other talented inventors underscore his role in enhancing healthcare solutions. As research continues, the implications of his work promise to improve therapeutic strategies for target diseases, potentially benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…